<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We performed optic nerve sheath decompression in 53 patients (101 eyes) with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> and <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Sixty-nine eyes (85 patients) with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001085'>papilledema</z:hpo> uniformly had improved visual function after optic nerve sheath decompression </plain></SENT>
<SENT sid="2" pm="."><plain>Of 32 eyes with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001085'>papilledema</z:hpo> (18 patients), only ten had improved visual function after optic nerve sheath decompression </plain></SENT>
<SENT sid="3" pm="."><plain>This difference was significant (P = .0001) </plain></SENT>
<SENT sid="4" pm="."><plain>Thirteen eyes required secondary or tertiary optic nerve sheath decompression after an initial successful result </plain></SENT>
<SENT sid="5" pm="."><plain>Eleven of 13 eyes had improved visual function after repeat optic nerve sheath decompression </plain></SENT>
<SENT sid="6" pm="."><plain>We believe that patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001085'>papilledema</z:hpo> and <z:hpo ids='HP_0000572'>visual loss</z:hpo> should be offered optic nerve sheath decompression, and if symptoms recur, repeat optic nerve sheath decompression is a safe and effective treatment option </plain></SENT>
</text></document>